DK151013C - Analogifremgangsmaade til fremstilling af 5-methyl-isoxazol-4-carboxylsyreanilider - Google Patents
Analogifremgangsmaade til fremstilling af 5-methyl-isoxazol-4-carboxylsyreaniliderInfo
- Publication number
- DK151013C DK151013C DK248376A DK248376A DK151013C DK 151013 C DK151013 C DK 151013C DK 248376 A DK248376 A DK 248376A DK 248376 A DK248376 A DK 248376A DK 151013 C DK151013 C DK 151013C
- Authority
- DK
- Denmark
- Prior art keywords
- acidanilides
- isoxazol
- analogy
- carboxylic
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/66—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2524959 | 1975-06-05 | ||
| DE2524959A DE2524959C2 (de) | 1975-06-05 | 1975-06-05 | 5-Methyl-isoxazol-4-carbonsäureanilide, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Mittel |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK248376A DK248376A (da) | 1976-12-06 |
| DK151013B DK151013B (da) | 1987-10-12 |
| DK151013C true DK151013C (da) | 1988-03-07 |
Family
ID=5948292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK248376A DK151013C (da) | 1975-06-05 | 1976-06-04 | Analogifremgangsmaade til fremstilling af 5-methyl-isoxazol-4-carboxylsyreanilider |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4087535A (ru) |
| JP (1) | JPS5938230B2 (ru) |
| AT (1) | AT349007B (ru) |
| BE (1) | BE842689A (ru) |
| CA (1) | CA1076584A (ru) |
| CH (1) | CH603608A5 (ru) |
| DK (1) | DK151013C (ru) |
| ES (1) | ES448386A1 (ru) |
| FR (1) | FR2313052A1 (ru) |
| GB (1) | GB1547452A (ru) |
| IE (1) | IE43136B1 (ru) |
| IT (1) | IT1063592B (ru) |
| LU (1) | LU75077A1 (ru) |
| MX (1) | MX3144E (ru) |
| NL (1) | NL178596C (ru) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2654797A1 (de) * | 1976-12-03 | 1978-06-08 | Hoechst Ag | Verfahren zur herstellung von isoxazolderivaten |
| JPS54102196U (ru) * | 1977-12-28 | 1979-07-18 | ||
| DE2854439A1 (de) * | 1978-12-16 | 1980-07-03 | Hoechst Ag | Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung |
| ATE14724T1 (de) * | 1979-06-11 | 1985-08-15 | Ciba Geigy Ag | Alphacarbamoyl-pyrrolpropionitrile, verfahren zu ihrer herstellung, sowie pharmazeutische praeparate die diese verbindungen enthalten. |
| DE2940189A1 (de) * | 1979-10-04 | 1981-04-16 | Basf Ag, 6700 Ludwigshafen | Isoxazolylcarbonsaeureanilide, verfahren zu ihrer herstellung und ihre verwendung als fungizide |
| FR2538806B1 (fr) * | 1982-12-30 | 1986-02-21 | Bago Sa Labor | Composes phenyl-3 methyl isoxazole-5 carboxy-4 anilides substitues, actifs therapeutiquement contre l'inflammation et la douleur |
| JPS6398092A (ja) * | 1986-10-14 | 1988-04-28 | 富士電機株式会社 | 金券用カ−ド残金精算装置 |
| US4935434A (en) * | 1988-01-26 | 1990-06-19 | Bristol-Myers Company | Antiarthritic isoxazole-4-carboxamides |
| DD297328A5 (de) | 1989-08-18 | 1992-01-09 | �������@���������k���Kk�� | 5-methyl-isoxalol-4-carbonsaeureanilide und 2 hydroxyethyliden-cyanoessigsaeureanilide zur behandlung von augenerkrankungen |
| US5583150A (en) * | 1989-08-18 | 1996-12-10 | Alcon Laboratories, Inc. | 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic anilides for the treatment of ocular diseases |
| US5001124A (en) * | 1990-02-02 | 1991-03-19 | Syntex (U.S.A.) Inc. | 4-isoxazolecarboxamide derivatives |
| US5108999A (en) * | 1990-02-02 | 1992-04-28 | Syntex (U.S.A.) Inc. | 4-isoxazolecarboxamide derivatives |
| US5494911A (en) * | 1990-05-18 | 1996-02-27 | Hoechst Aktiengesellschaft | Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use |
| DE4127737A1 (de) | 1991-08-22 | 1993-02-25 | Hoechst Ag | Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen |
| US6133301A (en) * | 1991-08-22 | 2000-10-17 | Aventis Pharma Deutschland Gmbh | Pharmaceuticals for the treatment of rejection reactions in organ transplantations |
| GB9320299D0 (en) * | 1993-10-01 | 1993-11-17 | Roussel Lab Ltd | Isoxazole derivatives |
| US5700823A (en) * | 1994-01-07 | 1997-12-23 | Sugen, Inc. | Treatment of platelet derived growth factor related disorders such as cancers |
| US6335356B1 (en) | 1994-01-07 | 2002-01-01 | Sugen, Inc. | Method of treating a patient by parenteral administration of a lipophilic compound |
| US5610173A (en) * | 1994-01-07 | 1997-03-11 | Sugen, Inc. | Formulations for lipophilic compounds |
| US5624946A (en) * | 1994-07-05 | 1997-04-29 | Williams; James | Use of leflunomide to control and reverse chronic allograft rejection |
| US5721277A (en) * | 1995-04-21 | 1998-02-24 | Sugen, Inc. | Compounds and methods for inhibiting hyper-proliferative cell growth |
| US6331555B1 (en) | 1995-06-01 | 2001-12-18 | University Of California | Treatment of platelet derived growth factor related disorders such as cancers |
| US6316479B1 (en) | 1997-05-19 | 2001-11-13 | Sugen, Inc. | Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders |
| ES2150808T3 (es) * | 1997-08-08 | 2000-12-01 | Aventis Pharma Gmbh | Forma cristalina de (4-trifluorometil)-anilida de acido 5-metilisoxazol-4-carboxilico. |
| US7691890B2 (en) | 1998-03-11 | 2010-04-06 | James W. Williams | Anti-viral uses of leflunomide products |
| US20050255071A1 (en) * | 1998-12-10 | 2005-11-17 | Aventis Pharma Deutschland Gmbh | Preparation having improved therapeutic breadth comprising nucleotide synthesis inhibitors |
| GB0123571D0 (en) * | 2001-04-05 | 2001-11-21 | Aventis Pharm Prod Inc | Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis |
| CA2443285C (en) | 2001-04-05 | 2007-08-21 | Aventis Pharmaceuticals Inc. | Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis |
| US20050158371A1 (en) * | 2002-02-12 | 2005-07-21 | Sumitomo Pharmaceuticals Co., Ltd. | Novel external agent |
| US8008501B2 (en) * | 2003-09-12 | 2011-08-30 | Rigel Pharmaceuticals, Inc. | Quinoline compounds and their uses |
| WO2006004865A1 (en) * | 2004-06-29 | 2006-01-12 | Rigel Pharmaceuticals, Inc. | 2-substituted quinoline compounds and their uses as inhibitors of the ige receptor signaling cascade |
| US20060024376A1 (en) * | 2004-07-30 | 2006-02-02 | The University Of Chicago | Methods and compositions for reducing toxicity associated with leflunomide treatment |
| JOP20190207A1 (ar) | 2017-03-14 | 2019-09-10 | Actelion Pharmaceuticals Ltd | تركيبة صيدلانية تشتمل على بونيسيمود |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK54063C (da) * | 1935-02-22 | 1937-12-27 | Hoffmann La Roche | Fremgangsmaade til Fremstilling af dialkylsubstituerede Amider af Isoksazolkarbonsyrer. |
| DE634286C (de) * | 1935-02-23 | 1936-08-26 | Hoffmann La Roche & Co Akt Ges | Verfahren zur Herstellung dialkylsubstituierter Amide von Isoxazolcarbonsaeuren |
| US2126329A (en) * | 1936-03-20 | 1938-08-09 | Hoffmann La Roche | Amide derivatives of isoxazole carboxylic acids |
| DE673111C (de) * | 1938-01-18 | 1939-03-16 | Hoffmann La Roche & Co Akt Ges | Verfahren zur Darstellung amidartiger Abkoemmlinge von Homologen der Isoxazolcarbonsaeuren |
| US2288863A (en) * | 1940-02-27 | 1942-07-07 | Hoffmann La Roche | Process for the manufacture of substituted amides of 3,5-dimethylisoxazole-4-carboxylic acid |
| DK58903C (da) * | 1940-02-27 | 1941-08-04 | Hoffmann La Roche | Fremgangsmaade til Fremstilling af substituerede Amider af 3,5-Dimetyl-isoksazol-karbonsyre-(4). |
-
1976
- 1976-05-31 ES ES448386A patent/ES448386A1/es not_active Expired
- 1976-05-31 NL NLAANVRAGE7605841,A patent/NL178596C/xx not_active IP Right Cessation
- 1976-06-02 CH CH696276A patent/CH603608A5/xx not_active IP Right Cessation
- 1976-06-03 US US05/692,306 patent/US4087535A/en not_active Expired - Lifetime
- 1976-06-03 LU LU75077A patent/LU75077A1/xx unknown
- 1976-06-03 IT IT23923/76A patent/IT1063592B/it active
- 1976-06-04 JP JP51065476A patent/JPS5938230B2/ja not_active Expired
- 1976-06-04 IE IE1202/76A patent/IE43136B1/en unknown
- 1976-06-04 DK DK248376A patent/DK151013C/da not_active IP Right Cessation
- 1976-06-04 MX MX000270U patent/MX3144E/es unknown
- 1976-06-04 GB GB23185/76A patent/GB1547452A/en not_active Expired
- 1976-06-04 CA CA254,134A patent/CA1076584A/en not_active Expired
- 1976-06-04 AT AT413776A patent/AT349007B/de not_active IP Right Cessation
- 1976-06-04 FR FR7617038A patent/FR2313052A1/fr active Granted
- 1976-06-08 BE BE167707A patent/BE842689A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK248376A (da) | 1976-12-06 |
| BE842689A (fr) | 1976-12-08 |
| IE43136B1 (en) | 1980-12-31 |
| GB1547452A (en) | 1979-06-20 |
| US4087535A (en) | 1978-05-02 |
| IT1063592B (it) | 1985-02-11 |
| CA1076584A (en) | 1980-04-29 |
| FR2313052B1 (ru) | 1979-09-28 |
| DK151013B (da) | 1987-10-12 |
| JPS527960A (en) | 1977-01-21 |
| ATA413776A (de) | 1978-08-15 |
| CH603608A5 (ru) | 1978-08-31 |
| NL178596C (nl) | 1986-04-16 |
| AT349007B (de) | 1979-03-12 |
| NL7605841A (nl) | 1976-12-07 |
| IE43136L (en) | 1976-12-05 |
| FR2313052A1 (fr) | 1976-12-31 |
| ES448386A1 (es) | 1978-04-16 |
| JPS5938230B2 (ja) | 1984-09-14 |
| MX3144E (es) | 1980-05-09 |
| LU75077A1 (ru) | 1977-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK151013C (da) | Analogifremgangsmaade til fremstilling af 5-methyl-isoxazol-4-carboxylsyreanilider | |
| DK148907C (da) | Analogifremgangsmaade til fremstilling af dihydrocyclosporin c | |
| DK49676A (da) | Fremgangsmade til fremstilling af hypolipidemiske midler | |
| DK149107C (da) | Analogifremgangsmaade til fremstilling af quinazolonderivater | |
| DK146205C (da) | Analogifremgangsmaade til fremstilling af 8alfa-ergolin-i-derivater | |
| DK113476A (da) | Fremgangsmade til fremstilling af amoxicillintrihydrat | |
| DK107876A (da) | Fremgangsmade til fremstilling af thiocarbamider | |
| DK535476A (da) | Fremgangsmade til fremstilling af 7-methoxycephalosporiner | |
| DK148139C (da) | Analogifremgangsmaade til fremstilling af 5-benzyl-2-oxazolidonderivater | |
| DK150676A (da) | Fremgangsmade til fremstilling af krystallinsk natrium-o-formyl-cefamandol | |
| DK150478C (da) | Analogifremgangsmaade til fremstilling af n-aryl-n-(4-piperidyl)-arylacetamidderivater | |
| DK146629C (da) | Analogifremgangsmaade til fremstilling af depotsteroidestere | |
| DK415576A (da) | Fremgangsmade til fremstilling af krystallinsk dipilocarpiniumpamoat | |
| DK399976A (da) | Fremgangsmade til fremstilling af aralkylamider | |
| DK29276A (da) | Fremgangsmade til fremstilling af 8-bromothieno-triazolo-1,4-diazepiner | |
| DK142845C (da) | Analogifremgangsmaade til fremstilling af imidazolderivater | |
| DK141584C (da) | Fremgangsmaade til fremstilling af slagseje vinylaromat-podecopolymere | |
| DK424676A (da) | Fremgangsmade til fremstilling af 2-alkylindan | |
| DK480676A (da) | Fremgangsmade til fremstilling af s-alkylphosphordihalogeniddithioater | |
| DK526676A (da) | Fremgangsmade til fremstilling af 4-chlor-2-butynyl-m-chlorcarbanilat | |
| DK158673C (da) | Analogifremgangsmaade til fremstilling af cephalosporinforbindelser. | |
| DK46476A (da) | Fremgangsmade til fremstilling af 5-nitrothiazolylimidazolidiner | |
| DK494289D0 (da) | Analogifremgangsmaade til fremstilling af terapeutisk anvendelige prostaglandianaloge | |
| DK579776A (da) | Fremgangsmade til fremstilling af 7-methoxy-cephalosporiner | |
| DK238776A (da) | Fremgangsmade til fremstilling af 3-brombenzaldehyd |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUP | Patent expired |